Prime

Kemri Ebola candidate vaccine passes Phase One trials

Dr Francis Kateh (right) volunteers to receive a trial vaccine against Ebola at Redemption Hospital on the outskirts of Monrovia, Liberia, in February. PHOTO | AFP

Initial results from Phase One trials of an Ebola candidate vaccine known as rVSV ZEBOV have shown that the vaccine is safe and generates an immune response against the deadly Ebola virus.

The trials began in December 2014 in Kilifi County and three other sites in Switzerland, Germany and Gabon.

PAYE Tax Calculator

Note: The results are not exact but very close to the actual.

Get it First!

Stay up to date on the editors' picks of the week.

Latest

  1. co-op-bank

    PRIME Co-op Bank faulted for flawed sacking of poor performer

  2. PRIME Breast cancer in men: Warning signs you should not ignore

  3. PRIME Kenya’s economy grows 5.1pc despite Iran war price shocks

  4. PRIME KPA gets nod for Mombasa, Lamu port asset concession tenders

In the headlines

View All